In this sense, secretion of hepatocyte growth factor (HGF) and IL-6 by CAFs has been related to lapatinib resistance in HER2+ breast cancer [16] and tamoxifen resistance [17], respectively. The gene discussed is HGF; the disease is breast cancer.